Genetic variants in “glucokinase regulatory protein” (GCKR) gene [16], “solute carrier family 2-member 1” (SLC2A1) gene [17], and “17-beta hydroxysteroid dehydrogenase 13” (HSD17B13) gene [18], have also been identified in patients with fatty liver disease. This evidence concerns the gene GCKR and fatty liver disease.